Northamber PLC (NAR)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 24.50 |
|---|---|
| 52-week range | 22.00 – 36.00 |
| Return, 1 month / 3 months | −2.0% / +8.9% |
| Return, 1 year / 3 years | −13.8% / −43.6% |
| Trend | Below its 200-day average |
| RSI (14) | 38 |
| Volatility (1 year) | 26.2% |
| Worst drawdown (1 year) | -32.5% |
| Average daily value traded | 0.05M GBX |
| Dividend yield | 2.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Northamber PLC is a distributor of information technology products based in the United Kingdom. The company supplies computer hardware, peripherals, networking equipment and related accessories, sourcing goods from manufacturers and passing them on to resellers, system builders and retailers. Its customers are trade buyers rather than the general public, and the business centres on warehousing, logistics and account management for technology products sold through the channel.
On this site Northamber PLC appears as a stock on the London Exchange (UK), code NAR, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Northamber PLC (NAR) trades on the London Exchange in UK. It last closed at GBX 24.50 on 23 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 2,511 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 13.8% and over the last three months it rose 8.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 30 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.6% | ||
| From 52-week high | -27.9% | ||
| Momentum | 46 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 8.9% | ||
| 6-month return | -9.3% | ||
| 12-month return, skipping the last month | -12.0% | ||
| Stability (higher is calmer) | 58 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 26.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.5% | ||
| Liquidity | 17 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.05M GBX | ||
| Zero-volume days | 48.3% | ||
| Income | 63 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.4% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −2.0% |
| 3 months | +8.9% |
| 6 months | −9.3% |
| 1 year | −13.8% |
| 3 years | −43.6% |
| 5 years | −54.5% |
Signals
| 50-day / 200-day average | 24.94 / 26.81 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.77 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Apr 2026 | GBP 0.0030 |
| 8 Jan 2026 | GBP 0.0030 |
| 10 Apr 2025 | GBP 0.0030 |
| 12 Dec 2024 | GBP 0.0030 |
| 11 Apr 2024 | GBP 0.0030 |
| 14 Dec 2023 | GBP 0.0030 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.